Literature DB >> 17293881

Mobilized peripheral blood stem cells provide rapid reconstitution but impaired long-term engraftment in a mouse model.

J S G Yeoh1, A Ausema, P Wierenga, G de Haan, R van Os.   

Abstract

In this study, we use competitive repopulation to compare the quality and frequency of stem cells isolated from mobilized blood with stem cells isolated from bone marrow (BM) in a mouse model. Lin(-)Sca-1(+)c-Kit(+) (LSK) cells were harvested from control BM and peripheral blood of mice following granulocyte colony-stimulating factor (G-CSF) administration. LSK cells were used because of their resemblance to human CD34(+) cells. We confirmed that transplantation of phenotypically defined mobilized peripheral blood (MPB) stem cells results in rapid recovery of blood counts. However, in vitro results indicated that LSK cells purified from MPB had lower cobblestone area-forming cell day 35 activity compared to BM. Additionally, evaluation of chimerism after co-transplantation of LSK cells purified from blood and BM revealed that MPB stem cells contained 25-fold less repopulation potential compared to BM stem cells. Competitive repopulating unit frequency analysis showed that freshly isolated MPB LSK cells have 8.8-fold fewer cells with long-term repopulating ability compared to BM LSK cells. Secondary transplantation showed no further decline in contribution of hematopoiesis relative to BM. We conclude that the reduced frequency of stem cells within the LSK population of MPB, rather than poorer quality, causes the reduced repopulation potential.Bone Marrow Transplantation (2007) 39, 401-409. doi:10.1038/sj.bmt.1705601; published online 12 February 2007.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17293881     DOI: 10.1038/sj.bmt.1705601

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  4 in total

1.  The nucleotide sugar UDP-glucose mobilizes long-term repopulating primitive hematopoietic cells.

Authors:  Sungho Kook; Joonseok Cho; Sean Bong Lee; Byeong-Chel Lee
Journal:  J Clin Invest       Date:  2013-07-25       Impact factor: 14.808

Review 2.  New agents in HSC mobilization.

Authors:  Mélanie J Domingues; Susan K Nilsson; Benjamin Cao
Journal:  Int J Hematol       Date:  2016-11-30       Impact factor: 2.490

3.  Bone marrow-derived cells can acquire renal stem cells properties and ameliorate ischemia-reperfusion induced acute renal injury.

Authors:  Xiaohua Jia; Xiaoqiang Xie; Guowei Feng; He Lű; Qinjun Zhao; Yongzhe Che; Yizhou Zheng; Zhongchao Han; Yong Xu; Zongjin Li; Deling Kong
Journal:  BMC Nephrol       Date:  2012-09-10       Impact factor: 2.388

4.  Therapeutic targeting and rapid mobilization of endosteal HSC using a small molecule integrin antagonist.

Authors:  Benjamin Cao; Zhen Zhang; Jochen Grassinger; Brenda Williams; Chad K Heazlewood; Quentin I Churches; Simon A James; Songhui Li; Thalia Papayannopoulou; Susan K Nilsson
Journal:  Nat Commun       Date:  2016-03-15       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.